Mesothelioma Legal News
Asbestos Disease Awareness Organization (ADAO), Asbestos in Products, Mesothelioma News, Organizations

ADAO Fact #7: Asbestos fibers can be nearly 700 times smaller than human hair and are odorless, tasteless, indestructible fibers that can remain suspended in the air for seconds

 

The ADAO’s “7 Facts for 7 Days” campaign today shares: “Asbestos fibers can be nearly 700 times smaller than human hair and are odorless, tasteless, indestructible fibers that can remain suspended in the air for seconds.” The tiny size of asbestos fibers means that many who worked with or near asbestos, had no idea they […]

Asbestos Disease Awareness Organization (ADAO), Asbestos in Products, Mesothelioma News, Organizations

ADAO Fact #6: Chrysotile asbestos accounts for nearly 95% of asbestos mined and exported today. In 2012, the top four asbestos producing countries were Russia, China, Brazil, and Kazakhstan

 

The ADAO’s “7 Facts for 7 Days” campaign today shares: “Chrysotile asbestos accounts for nearly 95% of asbestos mined and exported today. In 2012, the top four asbestos producing countries were Russia, China, Brazil, and Kazakhstan.” The amount of asbestos imported into the US peaked in 1973. Despite sharp declines in the important of asbestos, […]

Asbestos Disease Awareness Organization (ADAO), Asbestos in Products, Asbestos Legislation, Mesothelioma News, Organizations

ADAO Fact #5: The World Health Organization estimates that 107,000 workers die annually from exposure to asbestos

 

The ADAO’s “7 Facts for 7 Days” campaign today shares: “The World Health Organization estimates that 107,000 workers die annually from exposure to asbestos.” Thie fact is made all the more stark when you note that the WHO is only taking into account asbestos-related lung cancer, mesothelioma, and asbestosis in these estimates. From the “Asbestos: […]

Lung Cancer, Mesothelioma News

Cancer Cells Resistant To Cisplatin Are Sensitive To Experimental Anticancer Drugs, PARP Inhibitors

 

Poly (ADP-ribose) polymerase inhibitors may be a novel treatment strategy for patients with cancer that has become resistant to the commonly used chemotherapy drug cisplatin, according to data from a…

Asbestos Disease Awareness Organization (ADAO), Asbestos in Products, Mesothelioma News, Organizations

ADAO Fact #4: Asbestos-caused diseases have a 10 – 50 year latency period from initial exposure to development of disease

 

The ADAO’s “7 Facts for 7 Days” campaign today shares: “Asbestos-caused diseases have a 10 – 50 year latency period from initial exposure to development of disease.” The long latency period (the time between the exposure to asbestos and disease progression) in asbestos disease has robbed many workers of their retirement years just as they […]

Asbestos & Mesothelioma Studies, Asbestos Disease Awareness Organization (ADAO), Mesothelioma News, Organizations

ADAO Fact #3: Asbestos fibers can cause asbestosis, lung, and gastrointestinal cancers, and an aggressive cancer called mesothelioma. The average life expectancy of a mesothelioma patient is six-twelve months

 

The ADAO’s “7 Facts for 7 Days” campaign today shares: “Asbestos fibers can cause asbestosis, lung, and gastrointestinal cancers, and an aggressive cancer called mesothelioma. The average life expectancy of a mesothelioma patient is six-twelve months.” The World Health Organization (WHO) estimates that more than 100,000 people die annually as a result of asbestos related […]

Asbestos Disease Awareness Organization (ADAO), Asbestos in Products, Asbestos in Schools, Asbestos Legislation, Mesothelioma News, Organizations

ADAO Fact #2: 55 countries have banned asbestos, but the U.S. and Canada have not. In 2012 alone, the U.S. imported over 1,000 tons of asbestos.

 

The ADAO’s “7 Facts for 7 Days” campaign today shares: “55 countries have banned asbestos, but the U.S. and Canada have not. In 2012 alone, the U.S. imported over 1,000 tons of asbestos.” The European Union, Japan, Australia, and New Zealand are among the 55 countries that have banned asbestos. More than a decade ago, […]

Asbestos in Products, Environmental Protection Agency (EPA), Mesothelioma News, Organizations

Statement by the U.S. Surgeon General Dr. Regina Benjamin on National Asbestos Awareness Week 2013

 

During National Asbestos Awareness Week, April 1-7, I urge Americans to learn about the dangers of asbestos exposure. Asbestos is a mineral fiber that occurs naturally in our environment; in rock and in soil. Because of its fiber strength and heat resistance, asbestos has traditionally been used in a variety of building construction materials, as […]

Asbestos Disease Awareness Organization (ADAO), Mesothelioma News, Organizations

Asbestos Awareness Week: Asbestos is a known human carcinogen and there is no safe level of asbestos exposure.

 

April 1 marks the beginning of asbestos awareness week, dedicated to increasing awareness and educating people on the dangers of asbestos. The Asbestos Disease Awareness Organization (ADAO) is holding events each day this week during their “7 Reasons for 7 Days” campaign. ADAO lists these top 7 reasons to prevent asbestos exposure: Asbestos is a […]

Asbestos / Mesothelioma, Mesothelioma News

In Patients With An Inactive NF2 Gene, Mesothelioma Drug Slows Disease Progression

 

Preliminary findings from the first trial of a new drug for patients with mesothelioma show that it has some success in preventing the spread of the deadly disease in patients lacking an active…

Mesothelioma News

Mesothelioma drug slows disease progression in patients with an inactive NF2 gene

 

Preliminary findings from the first trial of a new drug for patients with mesothelioma show that it has some success in preventing the spread of the deadly disease in patients lacking an active tumour suppressor gene called NF2.

Mesothelioma News

Mesothelioma drug slows disease progression in patients with an inactive NF2 gene

 

Preliminary findings from the first trial of a new drug for patients with mesothelioma show that it has some success in preventing the spread of the deadly disease in patients lacking an active tumour suppressor gene called NF2.